Kidswell Bio

Kidswell Bio EBIT Margin

The EBIT Margin (Operating Margin) of Kidswell Bio (4584.T) as of Oct 18, 2026 is -5.44 %. In the previous year, EBIT Margin (Operating Margin) was 2.27 % — a change of -339.80% (lower).

EBIT Margin

-5.44 %

YoY

-339.80%

Last updated:

EBIT Margin (Operating Margin) of Kidswell Bio is 2026 -5.44 % . EBIT Margin (Operating Margin) of Kidswell Bio was 2025 2.27 % . It decreases by -339.80% lower compared to the previous year.

Kidswell Bio's operating (EBIT) margin stands at -5.4%, up from -41.5% several years earlier.

The Kidswell Bio EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
-78.81 JPY
Jan 1, 2020
-678.64 JPY
Jan 1, 2021
-98.29 JPY
Jan 1, 2022
-41.49 JPY
Jan 1, 2023
-22.32 JPY
Jan 1, 2024
-56.75 JPY
Jan 1, 2025
2.27 JPY
Jan 1, 2026
-5.44 JPY
The Kidswell Bio EBIT Margin history
YEAREBIT MarginYoY
-5.44 %-339.80%
2.27 %-104.00%
-56.75 %+154.27%
-22.32 %-46.21%
-41.49 %-57.78%
-98.29 %-85.52%
-678.64 %+761.14%
-78.81 %-8.58%
-86.20 %-23.64%
-112.89 %+59.76%
-70.66 %-72.47%
-256.70 %+50.94%
-170.06 %+2,773.17%
-5.92 %+287.43%
-1.53 %-38.88%
-2.50 %+62.15%
-1.54 %+11.65%
-1.38 %+194.84%
-0.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kidswell Bio Stock analysis

What does Kidswell Bio do? Kidswell Bio Corp, based in Chuo-Ku, Tokyo, operates in the Health Care sector with a focus on Biotechnology. The company develops biopharmaceutical products, including biosimilars for cancer, renal diseases, and eye conditions, as well as innovative therapies such as anti-RAMP2 antibodies and regenerative medicine using stem cells for pediatric heart diseases and congenital disorders. Listed on 30 November 2012, it employs 41 full-time staff. Kidswell Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kidswell Bio stock

EBIT Margin (Operating Margin) of Kidswell Bio is -5.44 % in 2026.

EBIT Margin (Operating Margin) of Kidswell Bio changed from 2.27 % to -5.44 %, representing a -339.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Kidswell Bio since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Kidswell Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Kidswell Bio

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Kidswell Bio